Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Braunstein Scott | Aug 5, 2024 | Sell | 12,145 | $1.13 | $14,000 |
| Shafer Christina | Aug 5, 2024 | Sell | 3,820 | $1.14 | $4,400 |
| Pfanstiel Steven | Aug 5, 2024 | Sell | 4,657 | $1.13 | $5,300 |
| MANNING MARTHA E | Aug 5, 2024 | Sell | 3,621 | $1.13 | $4,100 |
| Hulihan Joseph | Aug 5, 2024 | Sell | 4,828 | $1.13 | $5,500 |
| Shafer Christina | Feb 20, 2024 | Sell | 2,153 | $9.56 | $21,000 |
| MANNING MARTHA E | Feb 20, 2024 | Sell | 1,894 | $9.57 | $18,000 |
| Braunstein Scott | Feb 16, 2024 | Sell | 11,850 | $9.94 | $120,000 |
| Hulihan Joseph | Feb 16, 2024 | Sell | 2,814 | $9.98 | $28,000 |
| Pfanstiel Steven | Feb 16, 2024 | Sell | 3,092 | $9.97 | $31,000 |
| Shafer Christina | Aug 8, 2023 | Sell | 11 | $8.93 | $98 |
| Braunstein Scott | Aug 8, 2023 | Sell | 30 | $8.94 | $270 |
| Pfanstiel Steven | Aug 8, 2023 | Sell | 14 | $8.93 | $130 |
| MANNING MARTHA E | Aug 8, 2023 | Sell | 11 | $8.93 | $98 |
| Hulihan Joseph | Aug 8, 2023 | Sell | 13 | $8.93 | $120 |
| Shafer Christina | Aug 7, 2023 | Sell | 2,385 | $9.52 | $23,000 |
| Braunstein Scott | Aug 7, 2023 | Sell | 6,413 | $9.55 | $61,000 |
| Pfanstiel Steven | Aug 7, 2023 | Sell | 2,790 | $9.54 | $27,000 |
| MANNING MARTHA E | Aug 7, 2023 | Sell | 2,169 | $9.54 | $21,000 |
| Hulihan Joseph | Aug 7, 2023 | Sell | 2,889 | $9.55 | $28,000 |
| Fischer Seth H. Z. | Feb 6, 2023 | Sell | 1,018 | $6.54 | $6,700 |
| Austin Charles | Feb 6, 2023 | Sell | 1,073 | $6.49 | $7,000 |
| Ezickson Elan | Feb 6, 2023 | Sell | 750 | $6.56 | $4,900 |
What's the latest insider transaction for Marinus Pharmaceuticals?
The most recent insider transaction for Marinus Pharmaceuticals was conducted by Braunstein Scott, who sold 12,145 shares on August 5, 2024 at a price of $1.13 per share.
Which insider has sold the most MRNS stock over the last two years?
Braunstein Scott has sold the most MRNS stock in the last 2 years, with a total value of $190,000.
What is the total value of insider transactions for Marinus Pharmaceuticals (MRNS) in the last 2 years?
The total value of insider transactions for Marinus Pharmaceuticals in the last 2 years is negative, amounting to -$430,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Marinus Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Marinus Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
